Skip to main content
SpringerLink
Log in

Simultaneous measurement of biogenic amines and their metabolites in rat brain regions after acute administration of and abrupt withdrawal from butorphanol or morphine

  • Original Articles
  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

Changes in levels of biogenic amines and metabolites were measured using high performance liquid chromatography fitted with an electrochemical detection in various rat brain regions after acute administration of and abrupt withdrawal from continuous intracerebroventricular infusion of butorphanol (a μ/δ/κ mixed opioid receptor agonist) or morphine (a μ-opioid receptor agonist). A single dose of butorphanol (26 nmol/5 μl) or morphine (26 nmol/5 μl) increased levels of 3,4-dihydroxyphenylacetic acid in the striatum and limbic region and of homovanilic acid in the cortex, striatum, and limbic region. In animals which had been infused with butorphanol (26 nmol/μl/hr) or morphine (26 nmol/μl/hr) for 3 days, an increase in dopamine turnover was observed. The levels of 3,4-dihydroxyphenylacetic acid was decreased and that of homovanilic acid was increased in the striatum, limbic region, and midbrain immediately after termination of opioid infusion. Both dopamine metabolites (in these areas) were decreased at 2 and 6 hr after butorphanol or morphine withdrawal. Changes in norepinephrine, serotonin, and 5-hydroxyindoleacetic acid levels in some brain regions were observed in the morphine-, but not in butorphanol-dependent rats. These data suggest that the increase and the decrease in dopaminergic activity, but not noradrenergic and serotonergic neurons, in the some brain regions are closely associated with the production of antinociception of and the expression of withdrawal syndrome from butorphanol and morphine, respectively.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Miller, R. J. 1981. Peptides as neurotransmitters: focus on the enkephalin and endorphins. Pharm. Ther. 12:73–108.

    Google Scholar 

  2. Garcia-Sevilla, J. A., Ahtee, L., Magnusson, T., and Carlsson, A. 1978. Opiate-receptor mediated changes in monoamine synthesis in rat brain. J. Pharm. Pharmacol. 30:613–621.

    Google Scholar 

  3. Ahtee, L., Attila, L. M. J., Carlson, K. R., and Haikala, H. 1989. Changes in brain monoamine metabolism during withdrawal from chronic oral self-administration of morphine and in response to a morphine challenge in the withdrawn state. J. Pharmacol. Exp. Ther. 249:303–310.

    Google Scholar 

  4. Chiara, G. D., and Imperato, A. 1988. Opposite effects ofmu andkappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J. Pharmacol. Exp. Ther. 244:1067–1080.

    Google Scholar 

  5. Ahtee, L. 1980. Chronic morphine administration decreases 5-hydroxytryptamine and 5-hydroxyindoleacetic acid content in the brain of rats. Med. Biol. 58:38–44.

    Google Scholar 

  6. Attila, L. M. J., and Ahtee, L. 1983. Cerebral dopamine and noradrenaline turnover and effects of morphine test dose in rats withdrawn from 20 days morphine treatment. Med. Biol. 61:249–257.

    Google Scholar 

  7. Bhargava, H. N. 1979. The synthesis rate and turnover time of 5 hydroxytryptamine in brains of rats treated chronically with morphine. Br. J. Pharmacol. 65:311–317.

    Google Scholar 

  8. Bongianni, F., Carla, V., Moroni, F., and Pellegrini-Giampietro, D. E. 1986. Calcium channel inhibitors suppress the morphinewithdrawal syndrome in rats. Br. J. Pharmacol. 88:561–567.

    Google Scholar 

  9. Swann, A. C., Elsworth, J. D., Charney, D. S., Jablons, D. M., Roth, R. H., Redmond, D. E., and Maas, J. W. 1983. Brain catecholamine metabolites and behavior in morphine withdrawal. Eur. J. Pharmacol. 86:167–175.

    Google Scholar 

  10. Wood, P. L., Stotland, M., Richard, J. W., and Rackham, A. 1980. Actions ofmu, kappa, sigma, delta and agonist/antagonist opiates on striatal dopaminergic function. J. Pharmacol. Exp. Ther. 215: 697–703.

    Google Scholar 

  11. Goodlet, I., and Sugrue, M. F. 1974. Effect of acutely administered analgesic drugs on rat brain serotonin turnover. Eur. J. Pharmacol. 29:241–248.

    Google Scholar 

  12. Westerink, B. H. C., and Korf, J. 1976. Regional rat brain levels of 3,4-dihydroxyphenylacetic acid and homovanillic acid: concurrent fluorometric measurement and influence of drugs. Eur. J. Pharmacol. 38:281–291.

    Google Scholar 

  13. Bhargava, H. N., and Matwyshyn, G. A. 1977. Brain serotonin turnover and morphine tolerance-dependence induced by multiple intections in the rat. Eur. J. Pharmacol. 44:25–33.

    Google Scholar 

  14. Horan, P. J., and Ho, I. K. 1989. Comparative pharmacological and biochemical studies between butorphanol and morphine. Pharmacol. Biochem. Behav. 34:847–854.

    Google Scholar 

  15. Horan, P. J., and Ho, I. K. 1991. The physical dependence liability of butorphanol: a comparative study with morphine. Eur. J. Pharmacol. 203:387–391.

    Google Scholar 

  16. Jaw, S. P., Hoskins, B., and Ho, I. K. 1993. Involvement of δ-opioid receptors in physical dependence on butorphanol. Eur. J. Pharmacol. 240:67–72.

    Google Scholar 

  17. Jaw, S. P., Makimura, M., Hoskins, B., and Ho, I. K. 1993. Effect of norbinaltorphimine on butorphanol dependence. Eur. J. Pharmacol. 239:133–140.

    Google Scholar 

  18. Olt, K. W., Makimura, M., Jaw, S. P., Hoskins, B., and Ho, I. K. 1992. Effects of β-funaltrexamineon butorphanol dependence. Pharmacol. Biochem. Behav. 42:29–34.

    Google Scholar 

  19. Tokuyama, S., Feng, Y. Z., Wakabayashi, H., and Ho, I. K. 1995. Ca2+ channel blocker, diltiazem, prevents physical dependence and the enhancement of protein kinase C activity by opioid infusion in rats. Eur. J. Pharmacol. 279:93–98.

    Google Scholar 

  20. Tokuyama, S., Feng, Y. Z., Wakabayashi, H., and Ho, I. K. 1995. Possible involvement of protein kinases in physical dependence on opioids: studies using protein kinase inhibitors, H-7 and H-8. Eur. J. Pharmacol. 284:101–107.

    Google Scholar 

  21. Paxinos, G., and Watson, C. 1986. The rat brain in stereotaxic coordinates, 2nd ed. Orlando: Academic Press.

    Google Scholar 

  22. Glowinski, J., and Iversen, L. L. 1966. Regional studies of catecholamines in the rat brain-I. The disposition of [3H]-norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain. J. Neurochem. 13:655–669.

    Google Scholar 

  23. Watsubo, K., and Clouet, D. H. 1977. Effects of morphine and baloperidol on the electrical activity of rat nigrostriatal neurons. J. Pharmacol. Exp. Ther. 202:429–436.

    Google Scholar 

  24. Trulson, M. E., and Aresteh, K. 1983. Morphine increases the activity of midbrain dopamine neurons in vitro. Eur. J. Pharmacol. 114:105–109.

    Google Scholar 

  25. Korf, J., Bunney, B. S., and Aghajanian, G. K. 1974. Noradrenergic neurons: morphine inhibition of spontaneous activity. Eur. J. Pharmacol. 25:165–169.

    Google Scholar 

  26. Feng, Y. Z., Tseng, Y. T., Jaw, S. P., Hoskins, B., and Ho, I. K. 1994. Tolerance development to butorphanol: comparison with morphine. Pharmacol. Biochem. Behav. 49:649–655.

    Google Scholar 

  27. Feng, Y. Z., Narita, M., Tseng, Y. T., Hoskins, B., and Ho, I. K. 1994. Crosstolerance between butorphanol and morphine. Pharmacol. Biochem. Behav. 49:657–661.

    Google Scholar 

  28. Ahtee, L. 1973. Catalepsy and stereotyped behaviour in rats treated chronically with methadone: relation to brain homovanilic acid content. J. Pharm. Pharmacol. 25:649–651.

    Google Scholar 

  29. Ahtee, L. 1874. Catalepsy and stereotypies in rats treated with methadone: relation to striatal dopamine. Eur. J. Pharmacol. 27: 221–230.

    Google Scholar 

  30. Finne, U., Kataja, C., Pesonen, U., Kiianmaa, K., Attila, M., and Ahtee, L. 1977. Rotational behaviour in rats chronically treated with morphine during treatment and after withdrawal. Acta. Pharmacol. Toxicol. 41: Suppl 4:46.

    Google Scholar 

  31. Ahtee, Attila, P., Lauhakangas, V., Solkinen, A., and Sipila, J. 1987. The fall of homovanillic acid and 5-hydroxyindoleacetic acid concentrations in brain of mice withdrawn from repeated morphine treatment and their restoration by acute morphine administration. J. Neural. Transm. 68:63–78.

    Google Scholar 

  32. Baume de la, S., Patey, G., Marcais, H., Protais, P., Costentin, J., and Schwartz, J-C. 1979. Changes in dopamine receptors in mouse striatum following morphine treatments. Life Sci. 24:233 Suppl 4: 46.

    Google Scholar 

  33. Rosenman, S. J., and Smith, C. B. 1972.14C-Catecholamine synthesis in mouse brain during morphine withdrawal. Nature 240: 153–155.

    Google Scholar 

  34. Bhargava, H. N., and Gulati, A. 1990. Modification of brain and spinal cord dopamine D1 receptors labeled with3H-SCH 23390 following morphine withdrawal from tolerant and physically dependent rats. J. Pharmacol. Exp. Ther. 252:901–907.

    Google Scholar 

  35. Jaw, S. P., Hoskins, B., and Ho, I. K. 1993. Opioid antagonists and butorphanol dependence. Pharmacol. Biochem. Behav. 44: 497–500.

    Google Scholar 

  36. Charney, D. S., Redmond, D. E., Galloway, M. P., Kleber, H. D., Heninger, G. R., Murberg, M., and Roth, R. H. 1984. Naltrexone precipitates opiate withdrawal in methadone addicted human subjects: evidence for noradrenergic hyperactivity. Life Sci. 35:1263–1272.

    Google Scholar 

  37. Crawley, J. N., Laverty, R., and Roth, R. H. 1979. Clonidine reversal of increased norepinephrine metabolite levels during morphine withdrawal. Eur. J. Pharmacol. 57:247–250.

    Google Scholar 

  38. Gunne, L. M., Jonsson, J., and Fuxe, K. 1969. Effect of morphine intoxication on brain catecholamine neurons. Eur. J. Pharmacol. 5:338–342.

    Google Scholar 

  39. Laverty, R., and Roth, R. H. 1980. Clonidine reverses the increased norepinephrine turnover during morphine withdrawal in rats. Brain Res. 182:482–485.

    Google Scholar 

  40. Haubrich, D. R., and Blake, D. E. 1973. Modification of serotonin metabolism in rat brain after acute or chronic administration of morphine. Biochem. Pharmacol. 22:2753–2759.

    Google Scholar 

  41. Theiss, P., Papeschi, R., and Herz, A. 1975. Effects of morphine on the turnover of brain catecholamines and serotonin in ratschronic morphine administration. Eur. J. Pharmacol. 34:263–271.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology and Toxicology, University of Mississippi Medical Center, 2500 North State Street, 39216, Jackson, Mississippi

    Hiroyuki Wakabayashi, Shogo Tokuyama &  Ing K. Ho

Authors
  1. Hiroyuki Wakabayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shogo Tokuyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ing K. Ho
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wakabayashi, H., Tokuyama, S. & Ho, I.K. Simultaneous measurement of biogenic amines and their metabolites in rat brain regions after acute administration of and abrupt withdrawal from butorphanol or morphine. Neurochem Res 20, 1179–1185 (1995). https://doi.org/10.1007/BF00995381

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00995381

Key Words

Search

Navigation